Netherlands Colorectal Cancer Market Evolution Segmentation and Insight of Trends 2023 to 2028 with Top Countries Data

Report Overview

The Europe Colorectal Cancer market size stood at around USD 3.28 billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Colorectal cancers are the malignant tumours of the colon, which can lead to symptoms like blood in stool, abdominal discomfort, weight loss and more. These usually start by the formation of non-cancerous polyps, which can turn malignant over time. The polyps can be diagnosed by screening.

In Netherlands, colon cancer comes in the top 10 causes of death and disability combined. Even though colon cancer survival has increased in the recent years, Netherlands still has high incidence mortality compared to the surrounding regions. It is surpassed only by Hungary, Norway and Denmark.

In 2017, health care expenditures for colon cancer patients amounted to 597 million euros. This is 0.7% of the total expenditure on Dutch health. 87% of health care expenditure for colon cancer patients went to hospitals in 2017.

Market Drivers

The market is expected to be driven by the increased number of colorectal cancer screening tests. In Netherlands, screening for colorectal cancer was started in a phased manner in 2014. It targets individuals aged 55 to 75 years and uses stool test as a screening measure. On January 1, 2020, 82,900 individuals had colorectal cancer. Approximately 15,000 new patients are added each year.

Moreover, the risk of colorectal cancer increases with increasing age. Netherlands is associated with an aging population and this will act a market driver.

The market is also expected to grow due to increasing amount of research and development of new drugs

Get PDF Sample Report Now! @ https://www.prudentmarkets.com/sample-request/140082/

Top 5 Major Players

Top players in the market include Hoffman - LaRoche, Abott, Pfizer, Eli Lilly and Bristol - Myers Squibb.

The Netherlands Colorectal Cancer Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global Netherlands Colorectal Cancer market. This report explores all the key factors affecting the growth of the global Netherlands Colorectal Cancer market, including demand-supply scenario, pricing structure, profit margins, production, and value chain analysis.

To Know More About COVID-19 Impact On Netherlands Colorectal Cancer Market @ https://www.prudentmarkets.com/sample-request/140082/

Market Segmentation

By Diagnosis:

The market can be segmented into Digital Rectal Examination, Fecal Occult Blood Test, Colonoscopy, Virtual Colonoscopy and Flexible Sigmoidoscopy.

By Treatment:

On the basis of treatment, the market can be segmented into Surgery and Radiation Therapy, Chemotherapy and Targeted Therapies

By Geography::

By geography, the market is segmented according to the 12 provinces in Netherlands- Groningen, Friesland, Drenthe, Overijssel, Flevoland, Gelderland, Utrecht, Noord-Holland, Zuid-Holland, Zeeland, Noord-Brabant and Limburg. The number of incident cases in 2020 were maximum in Zuid-Holland (2,036), followed by Noord-Holland (1,704).

Top players in the market include Hoffman - LaRoche, Abott, Pfizer, Eli Lilly and Bristol - Myers Squibb.

Prudent Markets provides attractive discounts that fit your needs. Customization of the reports as per your requirement is also offered. Get in touch with our sales team, who will guarantee you a report that suits your needs.

Speak To Our Analyst For A Discussion On The Above Findings, And Ask For A Discount On The Report @ https://www.prudentmarkets.com/discount-request/140082/

The report covers the competitive analysis of the market. As the demand is driven by a buyer's paying capacity and the rate of item development, the report shows the important regions that will direct growth. This section exclusively shares insight into the budget reports of big-league members of the market helping key players and new entrants understand the potential of investments in the Global Netherlands Colorectal Cancer Market. It can be better employed by both traditional and new players in the industry for complete know-how of the market.

Strategic Points Covered in Table of Content of Global Netherlands Colorectal Cancer Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Netherlands Colorectal Cancer market
Chapter 2: Exclusive Summary - the basic information of the Netherlands Colorectal Cancer Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the Netherlands Colorectal Cancer
Chapter 4: Presenting the Netherlands Colorectal Cancer Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region/Country
Chapter 6: Evaluating the leading manufacturers of the Netherlands Colorectal Cancer market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

Any Questions? Feel Free To Enquire Here. We Will put you on the Right Path @ https://www.prudentmarkets.com/enquiry-request/140082/

Free Customization on the basis of client requirements on Immediate purchase:
1- Free country-level breakdown of any 5 countries of your interest.
2- Competitive breakdown of segment revenue by market players.

Customization of the Report:
This report can be customized to meet the client's requirements. Please connect with our sales team (sales@prudentmarkets.com), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +91 83560 50278 || USA/Canada(Toll Free): 1800-601-6071 to share your research requirements.

Get ready to Recognize the pros and cons of the regulatory framework, local reforms, and its effect on the Industry. Understand how the Leaders in Intelligent Network are keeping themselves one stage forward with our most up-to-date survey analysis.

In conclusion, the Netherlands Colorectal Cancer Market report is a genuine source for accessing the research data which is projected to exponentially grow your business. The report provides information such as economic scenarios, benefits, limits, trends, market growth rates, and figures. SWOT analysis and PESTLE analysis is also incorporated in the report.

Contact Us:
Allan Carter
Andheri, Maharashtra, 400102
USA/Canada(Toll Free): 1800-601-6071
Direct Line: +91 83560 50278
Mail: sales@prudentmarkets.com
Web: www.prudentmarkets.com

About Us:
We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy.

This release was published on openPR.